205 related articles for article (PubMed ID: 35528328)
1. The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses.
Zhao Y; Yan G; Mi J; Wang G; Yu M; Jin D; Tong X; Wang X
Comput Intell Neurosci; 2022; 2022():8400106. PubMed ID: 35528328
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
Guo J; Liu Z; Gong R
Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
[TBL] [Abstract][Full Text] [Related]
3. Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: Differential expression profile of circulating lncRNA
.
Yang Y; Lv X; Fan Q; Wang X; Xu L; Lu X; Chen T
Clin Nephrol; 2019 Jul; 92(1):25-35. PubMed ID: 31079598
[TBL] [Abstract][Full Text] [Related]
4. Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance.
Zhou LJ; Yang DW; Ou LN; Guo XR; Wu BL
J Diabetes Res; 2020; 2020():4729019. PubMed ID: 32832561
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.
Majumder S; Hadden MJ; Thieme K; Batchu SN; Niveditha D; Chowdhury S; Yerra VG; Advani SL; Bowskill BB; Liu Y; Vakili H; Alghamdi TA; White KE; Geldenhuys L; Siddiqi FS; Advani A
Diabetologia; 2019 Nov; 62(11):2129-2142. PubMed ID: 31399844
[TBL] [Abstract][Full Text] [Related]
6. Identification and construction of lncRNA-associated ceRNA network in diabetic kidney disease.
Wang Y; Tan J; Xu C; Wu H; Zhang Y; Xiong Y; Yi C
Medicine (Baltimore); 2021 Jun; 100(22):e26062. PubMed ID: 34087849
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNAs may impact podocytes and proximal tubule function through modulating miRNAs expression in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus patients.
Petrica L; Hogea E; Gadalean F; Vlad A; Vlad M; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Motoc A; Cretu OM; Radu D; Milas O; Golea-Secara A; Simulescu A; Mogos-Stefan M; Patruica M; Balint L; Ienciu S; Vlad D; Popescu R
Int J Med Sci; 2021; 18(10):2093-2101. PubMed ID: 33859515
[No Abstract] [Full Text] [Related]
8. The Impact of lncRNAs in Diabetes Mellitus: A Systematic Review and
Dieter C; Lemos NE; Corrêa NRF; Assmann TS; Crispim D
Front Endocrinol (Lausanne); 2021; 12():602597. PubMed ID: 33815273
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA ENSG00000254693 Promotes Diabetic Kidney Disease via Interacting with HuR.
Yu Q; Lin J; Ma Q; Li Y; Wang Q; Chen H; Liu Y; Liu B
J Diabetes Res; 2022; 2022():8679548. PubMed ID: 35493610
[TBL] [Abstract][Full Text] [Related]
10. The rs3931283/PVT1 and rs7158663/MEG3 polymorphisms are associated with diabetic kidney disease and markers of renal function in patients with type 2 diabetes mellitus.
Dieter C; Lemos NE; Girardi E; Ramos DT; Pellenz FM; Canani LH; Assmann TS; Crispim D
Mol Biol Rep; 2023 Mar; 50(3):2159-2169. PubMed ID: 36565414
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA NEAT1 is involved in the protective effect of Klotho on renal tubular epithelial cells in diabetic kidney disease through the ERK1/2 signaling pathway.
Yang YL; Xue M; Jia YJ; Hu F; Zheng ZJ; Wang L; Si ZK; Xue YM
Exp Mol Med; 2020 Feb; 52(2):266-280. PubMed ID: 32054986
[TBL] [Abstract][Full Text] [Related]
12. Identification of the candidate lncRNA biomarkers for acute kidney injury: a systematic review and meta-analysis.
Ma T; Jia H; Ji P; He Y; Chen L
Expert Rev Mol Diagn; 2021 Jan; 21(1):77-89. PubMed ID: 33612038
[No Abstract] [Full Text] [Related]
13. Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.
Alfaifi M; Ali Beg MM; Alshahrani MY; Ahmad I; Alkhathami AG; Joshi PC; Alshehri OM; Alamri AM; Verma AK
BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33436407
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA MALAT1 is upregulated in urine of type 1 diabetes mellitus patients with diabetic kidney disease.
Dieter C; Lemos NE; Girardi E; Ramos DT; Corrêa NRF; Canani LH; Bauer AC; Assmann TS; Crispim D
Genet Mol Biol; 2023; 46(2):e20220291. PubMed ID: 37272835
[TBL] [Abstract][Full Text] [Related]
15. LncRNA H19: a novel player in the regulation of diabetic kidney disease.
Wu Q; Huang F
Front Endocrinol (Lausanne); 2023; 14():1238981. PubMed ID: 37964955
[TBL] [Abstract][Full Text] [Related]
16. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease.
Zhang X; Chao P; Zhang L; Xu L; Cui X; Wang S; Wusiman M; Jiang H; Lu C
Front Immunol; 2023; 14():1030198. PubMed ID: 37063851
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis.
Assmann TS; Recamonde-Mendoza M; de Souza BM; Bauer AC; Crispim D
Mol Cell Endocrinol; 2018 Dec; 477():90-102. PubMed ID: 29902497
[TBL] [Abstract][Full Text] [Related]
18. Circulating expression and clinical significance of LncRNA ANRIL in diabetic kidney disease.
Zhu Y; Dai L; Yu X; Chen X; Li Z; Sun Y; Liang Y; Wu B; Wang Q; Wang X
Mol Biol Rep; 2022 Nov; 49(11):10521-10529. PubMed ID: 36129598
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy.
Chen S; Dong C; Qian X; Huang S; Feng Y; Ye X; Miao H; You Q; Lu Y; Ding D
J Diabetes Complications; 2017 Mar; 31(3):569-576. PubMed ID: 28007334
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
PeerJ; 2022; 10():e13932. PubMed ID: 36157062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
